US Archives - Page 24 of 100 - European Medical Journal

Inside the Hidden Threat of CNS Infections After Kidney Transplant

New 20-year study reveals that rare CNS infections in kidney transplant recipients carry high mortality and long-term neurological impact, with metagenomic sequencing crucial for diagnosis.

Pediatric Pulmonary Embolism More Common Than Once Thought

Pulmonary embolism in children may be more prevalent than previously recognized according to new findings from a large prospective multicenter study conducted across 21 pediatric emergency departments in the United States.

AMJ Dermatology 2 [Supplement 3] 2025

In this new article, discover recent clinical insights on clascoterone cream 1% and its potential role in addressing excess sebum…

Spotlight on Sebum Production

A recent study found that clascoterone cream 1% significantly reduces sebum production in patients with mild-to-moderate acne, suggesting…

FDA Fast Track Therapy Targets HER2-Mutated NSCLC: AACR 2025

Promising new data emerged on zongertinib, an investigational oral therapy targeting HER2 mutations in advanced non-small cell lung cancer (NSCLC), was presented at the AACR Annual Meeting 2025 in Chicago.

Are JAK Inhibitors Raising VTE Risk in Rheumatoid Arthritis?

In patients with rheumatoid arthritis (RA), understanding the risk of venous thromboembolism (VTE) is increasingly important as treatment strategies evolve.

Liquid Biopsy Detects Colorectal Cancer Recurrence Months Early: AACR 2025

At the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, new data revealed that a liquid biopsy using circulating tumor DNA (ctDNA) could detect colorectal cancer recurrence significantly earlier than imaging, with ctDNA signals appearing up to 416 days before clinical detection.

Acne Scar Treatments Evolve: Key Therapies Reviewed

Persistent acne scarring remains a major concern for patients and clinicians alike, with many individuals turning to invasive procedures in search of effective relief.

Off-the-Shelf Cell Therapy Induces Remission in Relapsed AML: AACR 2025

At the AACR Annual Meeting 2025 in Chicago, researchers unveiled promising early results from a novel cell therapy that could reshape treatment options for patients with relapsed or refractory acute myeloid leukemia (AML).

Immunotherapy Removes Surgery Need in dMMR Cancers: AACR 2025

Neoadjuvant immunotherapy using PD-1 blockade has demonstrated the potential to eliminate the need for surgery in patients with early-stage mismatch repair-deficient (dMMR) cancers, according to groundbreaking data presented at the AACR Annual Meeting 2025.